State Street reports 7% stake in SELLAS Life Sciences
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
State Street Corporation and certain investment adviser subsidiaries reported passive ownership of common stock of SELLAS Life Sciences Group Inc on a Schedule 13G. As of 06/30/2026, they beneficially owned 12,996,558 shares of common stock, representing 7% of the outstanding class. The group held 12,677,559 shares with shared voting power and 12,996,558 shares with shared dispositive power, with no sole voting or dispositive authority reported. Subsidiaries involved include SSGA Funds Management, Inc. and several State Street Global Advisors entities.
Key Figures
Key Terms
beneficially owned financial
parent holding company financial
investment company financial
Schedule 13G regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What stake in SELLAS Life Sciences Group Inc (SLS) does State Street report on this Schedule 13G?
How much voting power does State Street have in SELLAS Life Sciences Group Inc (SLS)?
What dispositive power does State Street hold over SLS common stock?
Which State Street entities are involved in the SLS 13G filing?
Who signed the Schedule 13G for SELLAS Life Sciences Group Inc (SLS)?
AI-generated analysis. How Rhea-AI works. Not financial advice.